Market Cap 598.53M
Revenue (ttm) 233.80M
Net Income (ttm) -15.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.69%
Debt to Equity Ratio 0.92
Volume 2,546,100
Avg Vol 2,848,888
Day's Range N/A - N/A
Shares Out 201.53M
Stochastic %K 64%
Beta 1.81
Analysts Strong Sell
Price Target $4.67

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivat...

Industry: Medical Devices
Sector: Healthcare
Phone: 925 288 6000
Address:
1220 Concord Avenue, Suite 600, Concord, United States
patten1962
patten1962 Aug. 18 at 12:21 AM
$CERS Hey everyone. I am thinking of jumping back into this company. Would love to have a discussion on why I should or should not. Not looking for pumpers and shorts but real investors. Question, is Ai somehow going to affect this company? Thank you in advance. @Afterbell @rooksleanne @MaxDanger
2 · Reply
healthcareguru
healthcareguru Aug. 17 at 4:38 PM
$CERS this should be soaring on Ebola concerns… I need a #WSB frenzy to break out here and run this baby up up to $8+!!! Internet - do your thing! 🔥😍 $XLV $IWM $XBI
0 · Reply
Violenteer
Violenteer Aug. 15 at 5:38 AM
$CERS l60% chance they stay independent through the next few years, 30% partnership, 10% outright sale
0 · Reply
cambo_retire
cambo_retire Aug. 14 at 6:47 PM
$CERS ding ding ding! and there it is-you guys willed it to 3
0 · Reply
OldManLogan
OldManLogan Aug. 14 at 6:33 PM
$CERS Please no BO before RBC readout and re-rating... If someone wants to buy us out at a premium, they can do so at a premium to $5-6 not at a premium to $3.
0 · Reply
healthcareguru
healthcareguru Aug. 14 at 4:19 PM
$CERS Get to work!! >$3 close today! 🦾 Biggest catalyst in the company’s history coming in 4Q (RBC)…this will be $5+ easy when that hits. 🔥 $XLV $XBI $IWM
0 · Reply
cambo_retire
cambo_retire Aug. 14 at 1:44 PM
$CERS wouldn't mind a consolidation around 2.80-we've had quite the good run since earnings and the overreaction-rest and run-GL
0 · Reply
healthcareguru
healthcareguru Aug. 13 at 4:53 PM
$CERS I want this>$3 by tmrw close…DO YOUR JOB! 🦾🔥
0 · Reply
Violenteer
Violenteer Aug. 13 at 2:50 PM
$CERS Bull case is getting stronger.. Growing revenue. Raised guidance. Multiple catalysts ahead. The stock got crushed. The business didn't. $CERS looks like a broken stock, not a broken company. I'm bullish.
0 · Reply
Acamus
Acamus Aug. 13 at 2:44 PM
$CERS I want to believe in you, baby, but I've been hurt before and you keep saying you'll change or this time will be different, but it never is.
0 · Reply
Latest News on CERS
Cerus Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Cerus Earnings Call Transcript: Q2 2026


Cerus Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Cerus Earnings release: Q2 2026


Cerus Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Cerus Quarterly report: Q2 2026


Cerus Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Cerus Slides: Q2 2026


Cerus reports Q2 EPS (1c), two estimates (1c)

2026-07-30T20:06:27.000Z - 19 days ago

Cerus reports Q2 EPS (1c), two estimates (1c)


Cerus closes debt facility up to $110M

2026-06-08T12:45:42.000Z - 2 months ago

Cerus closes debt facility up to $110M


Cerus Transcript: AGM 2026

Jun 2, 2026, 12:00 PM EDT - 2 months ago

Cerus Transcript: AGM 2026


Cerus management to meet with Craig-Hallum

2026-05-07T02:35:32.000Z - 3 months ago

Cerus management to meet with Craig-Hallum


Cerus upgraded to Buy from Neutral at BTIG

2026-05-01T12:43:03.000Z - 3 months ago

Cerus upgraded to Buy from Neutral at BTIG


Cerus Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Cerus Earnings Call Transcript: Q1 2026


Cerus Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Cerus Earnings release: Q1 2026


Cerus Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

Cerus Quarterly report: Q1 2026


Cerus reports Q1 EPS (1c), consensus (4c)

2026-04-30T20:23:26.000Z - 3 months ago

Cerus reports Q1 EPS (1c), consensus (4c)


Cerus Corporation Announces First Quarter 2026 Financial Results

Apr 30, 2026, 4:01 PM EDT - 3 months ago

Cerus Corporation Announces First Quarter 2026 Financial Results


Cerus announces new, four-year supply agreement with EFS

2026-04-27T12:14:12.000Z - 4 months ago

Cerus announces new, four-year supply agreement with EFS


Cerus Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Cerus Proxy statement: Proxy filing


Cerus Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Cerus Proxy statement: Proxy filing


Cerus Slides: Corporate presentation

Apr 22, 2026, 7:00 AM EDT - 4 months ago

Cerus Slides: Corporate presentation


Cerus names Vivek Jayaraman as CEO

2026-03-16T20:12:13.000Z - 5 months ago

Cerus names Vivek Jayaraman as CEO


Cerus Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 5 months ago

Cerus Slides: Corporate presentation


Cathie Wood’s ARK Investment buys 612K shares of Cerus today

2026-03-06T01:55:10.000Z - 5 months ago

Cathie Wood’s ARK Investment buys 612K shares of Cerus today


Cerus Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 10:30 AM EST - 6 months ago

Cerus Transcript: TD Cowen 46th Annual Health Care Conference


Cerus Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Cerus Earnings Call Transcript: Q4 2025


Cerus Annual report: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Cerus Annual report: Q4 2025


Cerus Earnings release: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Cerus Earnings release: Q4 2025


Cerus reports Q4 EPS (1c), two estimates 0c

2026-03-02T21:06:15.000Z - 6 months ago

Cerus reports Q4 EPS (1c), two estimates 0c


Cerus backs FY26 product revenue view $224M-$228M

2026-03-02T21:05:10.000Z - 6 months ago

Cerus backs FY26 product revenue view $224M-$228M


Cerus reports preliminary Q4 revenue $57.8M, consensus $59.31M

2026-01-11T22:15:24.000Z - 7 months ago

Cerus reports preliminary Q4 revenue $57.8M, consensus $59.31M


Cerus sees FY26 product revenue $224M-$228M

2026-01-11T22:15:15.000Z - 7 months ago

Cerus sees FY26 product revenue $224M-$228M


Cerus Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Cerus Earnings Call Transcript: Q3 2025


Cerus Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Cerus Quarterly report: Q3 2025


Cerus Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Cerus Earnings release: Q3 2025


Cerus reports Q3 EPS 0c, two estimates (3c)

2025-11-06T21:18:18.000Z - 10 months ago

Cerus reports Q3 EPS 0c, two estimates (3c)


Cerus Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 10:55 AM EDT - 1 year ago

Cerus Transcript: Cantor Global Healthcare Conference 2025


Cerus Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q2 2025


Cerus Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cerus Quarterly report: Q2 2025


Cerus Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings release: Q2 2025


Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 13, 2025, 4:01 PM EDT - 1 year ago

Cerus Corporation Celebrates World Blood Donor Day 2025


Cerus Proxy statement: Proxy Filing

May 23, 2025, 8:00 AM EDT - 1 year ago

Cerus Proxy statement: Proxy Filing


Cerus Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q1 2025


Cerus Quarterly report: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Cerus Quarterly report: Q1 2025


Cerus Earnings release: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings release: Q1 2025


Cerus Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Cerus Proxy statement: Proxy Filing


Cerus Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Cerus Proxy statement: Proxy Filing


Cerus Slides: Corporate Presentation

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Cerus Slides: Corporate Presentation


Cerus Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 5, 2025, 11:10 AM EST - 1 year ago

Cerus Transcript: TD Cowen 45th Annual Healthcare Conference


Cerus Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Earnings Call Transcript: Q4 2024


Cerus Annual report: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Annual report: Q4 2024


Cerus Earnings release: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Earnings release: Q4 2024


Cerus Slides: Q4 2024

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Slides: Q4 2024


Cerus Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 4:10 PM EST - 1 year ago

Cerus Transcript: Stifel 2024 Healthcare Conference


Cerus Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q3 2024


Cerus Quarterly report: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Quarterly report: Q3 2024


Cerus Earnings release: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings release: Q3 2024


Cerus Slides: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Slides: Q3 2024


Cerus Transcript: Study Update

Oct 16, 2024, 5:00 PM EDT - 1 year ago

Cerus Transcript: Study Update


Cerus Press release: Study Update

Oct 16, 2024, 5:00 PM EDT - 1 year ago

Cerus Press release: Study Update


Cerus Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q2 2024


Cerus Quarterly report: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Cerus Quarterly report: Q2 2024


Cerus Earnings release: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings release: Q2 2024


Cerus Corporation Celebrates World Blood Donor Day 2024

Jun 14, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2024


Cerus Earnings Call Transcript: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q1 2024


Cerus Quarterly report: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Cerus Quarterly report: Q1 2024


Cerus Earnings release: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings release: Q1 2024


Cerus Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cerus Proxy statement: Proxy Filing


Cerus Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cerus Proxy statement: Proxy Filing


patten1962
patten1962 Aug. 18 at 12:21 AM
$CERS Hey everyone. I am thinking of jumping back into this company. Would love to have a discussion on why I should or should not. Not looking for pumpers and shorts but real investors. Question, is Ai somehow going to affect this company? Thank you in advance. @Afterbell @rooksleanne @MaxDanger
2 · Reply
healthcareguru
healthcareguru Aug. 17 at 4:38 PM
$CERS this should be soaring on Ebola concerns… I need a #WSB frenzy to break out here and run this baby up up to $8+!!! Internet - do your thing! 🔥😍 $XLV $IWM $XBI
0 · Reply
Violenteer
Violenteer Aug. 15 at 5:38 AM
$CERS l60% chance they stay independent through the next few years, 30% partnership, 10% outright sale
0 · Reply
cambo_retire
cambo_retire Aug. 14 at 6:47 PM
$CERS ding ding ding! and there it is-you guys willed it to 3
0 · Reply
OldManLogan
OldManLogan Aug. 14 at 6:33 PM
$CERS Please no BO before RBC readout and re-rating... If someone wants to buy us out at a premium, they can do so at a premium to $5-6 not at a premium to $3.
0 · Reply
healthcareguru
healthcareguru Aug. 14 at 4:19 PM
$CERS Get to work!! >$3 close today! 🦾 Biggest catalyst in the company’s history coming in 4Q (RBC)…this will be $5+ easy when that hits. 🔥 $XLV $XBI $IWM
0 · Reply
cambo_retire
cambo_retire Aug. 14 at 1:44 PM
$CERS wouldn't mind a consolidation around 2.80-we've had quite the good run since earnings and the overreaction-rest and run-GL
0 · Reply
healthcareguru
healthcareguru Aug. 13 at 4:53 PM
$CERS I want this>$3 by tmrw close…DO YOUR JOB! 🦾🔥
0 · Reply
Violenteer
Violenteer Aug. 13 at 2:50 PM
$CERS Bull case is getting stronger.. Growing revenue. Raised guidance. Multiple catalysts ahead. The stock got crushed. The business didn't. $CERS looks like a broken stock, not a broken company. I'm bullish.
0 · Reply
Acamus
Acamus Aug. 13 at 2:44 PM
$CERS I want to believe in you, baby, but I've been hurt before and you keep saying you'll change or this time will be different, but it never is.
0 · Reply
Spooky22
Spooky22 Aug. 12 at 9:58 PM
$CERS @OldManLogan You were totally right back then. It might not continue like that as fast as it did the last days, but another move upward in anticipation of the readout is inevitable imo.
0 · Reply
healthcareguru
healthcareguru Aug. 12 at 6:36 PM
$CERS RBC trial readout in 4Q…can be major catalyst on top of already consistently beating/raising guidance…see you at $5+. 🦾🔥 $XLV $XBI
0 · Reply
OldManLogan
OldManLogan Aug. 12 at 3:27 PM
$CERS 8 days ahead of schedule...
0 · Reply
OldManLogan
OldManLogan Aug. 12 at 11:58 AM
$CERS Low twos was a complete gift. Stock still undervalued relative to longterm potential... especially with the RBC program upcoming...
0 · Reply
sk7777777
sk7777777 Aug. 11 at 2:46 PM
$CERS Call me when it hit 4. Then I want to start keeping watch. Thanks
0 · Reply
sk7777777
sk7777777 Aug. 11 at 2:06 PM
$CERS Set it and forget it.
0 · Reply
sk7777777
sk7777777 Aug. 11 at 1:32 PM
$CERS I believe these are great reasons to be here and we have a gap to fill on the daily at 2.84ish and continue past 3. Cathie Wood recently purchased 87,357 shares of Cerus Corp (CERS) for ARK InvestStrong Fundamental Momentum and currently holds roughly 19.2 million shares. In its recent Q2 2026 earnings report, Cerus reported that revenue grew 10% year-over-year to $63.3 million. Raised Guidance: Management felt confident enough to raise full-year 2026 product revenue guidance to a range of $229 million to $231 million. Improved Financial Health: The company achieved its eighth consecutive quarter of positive adjusted EBITDA and successfully refinanced its debt, cutting annual interest expenses by up to $3.5 million. Catalysts on the Horizon: Cerus recently submitted its INT200 platelet application to the FDA, with a potential approval window opening in the first half of 2027. Recent upgrade from BTIG to Buy on 5/1/2026.
0 · Reply
cambo_retire
cambo_retire Aug. 10 at 7:25 PM
$CERS retesting the 100sma-let’s fill that gap!
0 · Reply
cambo_retire
cambo_retire Aug. 8 at 1:49 PM
$CERS yesterday was a lousy close-up all day as high as 2.42 then sells off in the last fifteen minutes on strong volume-who's dumping? we need some good news.
0 · Reply
OldManLogan
OldManLogan Aug. 5 at 6:59 PM
$CERS Get back up there Cerus, you got no bidness being under $3 with all the progress that's being made toward profitability and product expansion and all that.
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 5 at 2:04 PM
$CERS There u go.. $2.40 Possible now another overnight swing winner 🥇 🥇
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 5 at 1:53 PM
$CERS $2.24 Major resistance has to break for more.. Lets get that money🚨🚨
0 · Reply